Low-density lipoprotein stimulates mesangial cell proteoglycan and hyaluronan synthesis

Nephrology Dialysis Transplantation

Volumn 15, Issue 2, 2000, Pages 167-172

  Chana, Ravinder S ^a,b   Wheeler, David C ^a,b   Thomas, Gareth J ^a   Williams, John D ^a   Davies, Malcolm ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Glomerulosclerosis; Hyaluronan; Lipid; Low density lipoprotein; Mesangial cell; Proteoglycans

Indexed keywords

CHONDROITIN SULFATE; DECORIN; GLUCOSAMINE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; LOW DENSITY LIPOPROTEIN; PERLECAN; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; SULFATE; VERSICAN;

ARTICLE; CELL LABELING; CONTROLLED STUDY; CULTURE MEDIUM; DOSE TIME EFFECT RELATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOBLOTTING; ISOTOPE LABELING; KIDNEY DISEASE; MESANGIUM CELL; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS;

EID: 0033969744     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.2.167     Document Type: Article

References (25)

1. Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. New Engl J Med 1988; 318: 1657-1666
2. Keane WF, Kasiske BL, O'Donnell MP, Kim Y. Hypertension, hyperlipidemia, and renal damage. Am J Kidney Dis 1993; 21: 43-50
3. van Goor H, van der Horst ML, Atmosoerodjo J, Joles JA, van Tol A, Grond J. Renal apolipoproteins in nephrotic rats. Am J Pathol 1993; 142: 1804-1812
4. Vijayagopal P. Enhanced synthesis and accumulation of proteoglycans in cholesterol-enriched arterial smooth muscle cells. Biochem J 1993; 294: 603-611
5. Rosenblum ND. The mesangial matrix in the normal and sclerotic glomerulus. Kidney Int 1994; 45 [Suppl]: S73-77
6. Laurent TC, Fraser JRE. Hyaluronan. FASEB J 1992; 6: 2397-2404
7. Thomas GJ, Mason RM, Davies M. Characterization of proteoglycans synthesized by human adult glomerular mesangial cells in culture. Biochem J 1991; 277: 81-88
8. Thomas GJ, Bayliss MT, Harper K, Mason RM, Davies M. Glomerular mesangial cells in vitro synthesize an aggregating proteoglycan immunologically related to versican. Biochem J 1994; 302: 49-56
9. Wheeler DC, Chana RS. Interactions between lipoproteins, glomerular cells and matrix. Miner Electrolyte Metab 1993; 19: 149-164
10. Wheeler DC, Chana R, Topley N, Petersen MM, Davies M, Williams JD. Oxidation of low density of lipoprotein by mesangial cells may promote gomerular damage. Kidney Int 1994; 45: 1628-1636
11. Thomas GJ, Jenner L, Mason RM, Davies M. Human glomerular epithelial cell proteoglycans. Arch Biochem Biophys 1990; 278: 11-20
12. Beavan LA, Davies M, Mason RM. Renal glomerular proteoglycans; An investigation of their synthesis in vivo using a technique for fixation in situ. Biochem J 1988; 251: 411-418
13. Thomas GJ, Shewring L, McCarthy KJ, Couchman JR, Mason RM, Davies M. Rat mesangial cells in vitro synthesize a spectrum of proteoglycan species including those of the basement membrane and interstitium. Kidney Int 1995; 48: 1278-1289
14. Yung S, Coles GA, Williams JD, Davies M. The source and possible significance of hyaluronan in the peritoneal cavity. Kidney Int 1994; 46: 527-533
15. Farndale RW, Sayers CA, Barrett AJ. A direct spectrophotometric microassay for sulphated glycosaminoglycans in cartilage cultures. Conn Tiss Res 1982; 9: 247-248
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
17. Wheeler DC, Chana R, Thomas GJ, Steadman R, Williams JD, Davies M. Low density lipoprotein stimulate the production of hyaluronan by human mesangial cells in vitro. J Am Soc Nephrol 1994; 5: 823
18. Border WA, Noble NA, Yamamoto T et al. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 1992; 360: 361-364
19. Watanabe Y, Kashihara N, Makino H, Kanwar YS. Modulation of glomerular proteoglycans by Insulin-Like growth factor-1. Kidney Int 1992; 41: 1262-1273
20. van Det NF, van den Born J, Tamsma JT et al. Effects of high glucose on the production of heparan sulfate proteoglycan by mesangial and epithelial cells. Kidney Int 1996; 49: 1079-1089
21. Srinivasan SR, Vijayagopal P, Eberle K, Radhakrishnamurthy B, Berenson GS. Low-density lipoprotein binding affinity of arterial wall proteoglycans: characteristics of a chondroitin sulfate proteoglycan subfraction. Biochim Biophys Acta 1989; 1006: 159-166
22. Aviezer D, Levy E, Safrant M et al. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem 1994; 269: 114-121
23. Couchman JR, Beavan LA, McCarthy KJ. Glomerular matrix: synthesis, turnover and role in mesangial expansion. Kidney Int 1994; 45: 328-335
24. Davies M, Thomas GJ, Shewring LD, Mason RM. Mesangial cell proteoglycans: synthesis and metabolism. J Am Soc Nephrol 1992; 2:S88-94
25. Schonherr E, Jarvelainen HT, Sandell LJ, Wight TN. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem 1991; 266: 17640-17647